APGE Stock Analysis: Buy, Sell, or Hold?
APGE - Apogee Therapeutics, Inc. Common Stock
$133.74
0.09 (0.06%)
▲
5d:
+0.18%
30d:
+61.67%
90d:
+55.02%
WAIT
LOW Confidence
Analysis Updated: Jul 10, 2026 12:00 AM ET
Earnings: Aug 10, 2026
27d
Smart Money Distribution
None View Scanner →
Strength: 7.0/10
Get Alerted When APGE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: APGE shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: APGE shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: APGE is currently trading at $133.74, which is considered extended relative to its 30-day fair value range of $84.62 to $132.20.
Technical Outlook: Technically, APGE is in a strong uptrend. The price is currently testing key support at $132.55. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, APGE is in a strong uptrend. The price is currently testing key support at $132.55. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$84.62 -
$132.20
Company Quality Score
57/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
40.5%
Protect Your Profits
APGE is technically overbought (RSI 81). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (40/100)
- NEUTRAL: Near Wall St target ($130.53)
Trading Range Analysis
30-Day Trading Range
$84.62 -
$132.20
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$132.55
Resistance Level
$133.87
Current Trend
Strong Uptrend
Technical data as of
Jul 10, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-25.76
Wall Street Target
$130.53
(-2.3%)
Share & Embed Analysis
Last updated: July 13, 2026 12:43 PM ET
Data refreshes hourly during market hours. Next update: 1:43 PM
Data refreshes hourly during market hours. Next update: 1:43 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is APGE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
7
Sells
Net
INSIDERS SELLING
Recent Transactions
Michael Thomas Henderson
SELL
20000 shares
2026-04-08
Carl Dambkowski
SELL
5500 shares
2026-04-01
Michael Thomas Henderson
SELL
20000 shares
2026-03-11
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 57 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$108 | 64 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 56 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$111 | 58 HOLD |
|
CLDX
Celldex Therapeutics Inc |
STRONG BUY
15 analysts |
$58 | 61 BUY |
Advanced APGE Option Strategies
Professional options setups generated by AI based on today's APGE price and gamma walls.
